Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis
- PMID: 16145172
- PMCID: PMC1234079
- DOI: 10.1128/JCM.43.9.4902-4904.2005
Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis
Abstract
Aspergillus ustus is an uncommon clinical species which is poorly susceptible to antifungals. We report two cases of A. ustus infections that occurred in allogeneic stem cell transplant recipients while they were receiving either voriconazole or caspofungin. Prolonged use of these new antifungal agents may increase the risk of the emergence of resistant organisms.
Figures
Similar articles
-
Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.Int J Antimicrob Agents. 2007 Dec;30(6):551-4. doi: 10.1016/j.ijantimicag.2007.07.026. Int J Antimicrob Agents. 2007. PMID: 18029149
-
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.Transplantation. 2006 Feb 15;81(3):320-6. doi: 10.1097/01.tp.0000202421.94822.f7. Transplantation. 2006. PMID: 16477215 Clinical Trial.
-
Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell graft.Eur J Haematol. 2005 May;74(5):438-41. doi: 10.1111/j.1600-0609.2004.00384.x. Eur J Haematol. 2005. PMID: 15813919
-
[Efficacies and clinical roles of new antifungal agents].Nihon Ishinkin Gakkai Zasshi. 2006;47(3):155-9. doi: 10.3314/jjmm.47.155. Nihon Ishinkin Gakkai Zasshi. 2006. PMID: 16940948 Review. Japanese.
-
Antifungal prophylaxis in haematology patients: the role of voriconazole.Clin Microbiol Infect. 2012 Apr;18 Suppl 2:1-15. doi: 10.1111/j.1469-0691.2012.03772.x. Clin Microbiol Infect. 2012. PMID: 22409648 Review.
Cited by
-
Cerebral aspergillosis caused by Aspergillus granulosus.J Clin Microbiol. 2009 Oct;47(10):3386-90. doi: 10.1128/JCM.00588-09. Epub 2009 Aug 26. J Clin Microbiol. 2009. PMID: 19710280 Free PMC article.
-
Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature.Eur J Med Res. 2011 Apr 28;16(4):153-7. doi: 10.1186/2047-783x-16-4-153. Eur J Med Res. 2011. PMID: 21486729 Free PMC article. Review.
-
Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient.Mycopathologia. 2020 Apr;185(2):399-403. doi: 10.1007/s11046-019-00423-x. Epub 2020 Jan 10. Mycopathologia. 2020. PMID: 31925638
-
Polyphasic taxonomy of Aspergillus section Usti.Stud Mycol. 2007;59:107-28. doi: 10.3114/sim.2007.59.12. Stud Mycol. 2007. PMID: 18490949 Free PMC article.
-
In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods.Antimicrob Agents Chemother. 2013 Feb;57(2):1065-8. doi: 10.1128/AAC.01588-12. Epub 2012 Dec 10. Antimicrob Agents Chemother. 2013. PMID: 23229479 Free PMC article.
References
-
- Ascioglu, S., J. H. Rex, B. de Pauw, J. E. Bennett, J. Bille, F. Crokaert, D. W. Denning, J. P. Donnelly, J. E. Edwards, Z. Erjavec, D. Fiere, O. Lortholary, J. Maertens, J. F. Meis, T. F. Patterson, J. Ritter, D. Selleslag, P. M. Shah, D. A. Stevens, and T. J. Walsh. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7-14. - PubMed
-
- Baddley, J. W., T. P. Stroud, D. Salzman, and P. G. Pappas. 2001. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin. Infect. Dis. 32:1319-1324. - PubMed
-
- Bretagne, S., A. Marmorat-Khuong, M. Kuentz, J. P. Latge, E. Bart-Delabesse, and C. Cordonnier. 1997. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J. Infect. 35:7-15. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical